Cargando…

A life for autoimmune blistering diseases: in memoriam Detlef Zillikens

Detlef Zillikens, MD, director and chair of the Department of Dermatology at the University of Lübeck, Lübeck, Germany, died in September 2022, aged only 64. He dedicated his professional life to autoimmune blistering diseases (AIBDs) and built his department into one of the world’s leading centers...

Descripción completa

Detalles Bibliográficos
Autores principales: Hundt, Jennifer E., Sadik, Christian D., van Beek, Nina, Busch, Hauke, Caux, Frédéric, Goebeler, Matthias, Hammers, Christoph M., Hartmann, Karin, Hashimoto, Takashi, Ibrahim, Saleh, Kasperkiewicz, Michael, Murrell, Dedee F., Recke, Andreas, Rose, Christian, Schumacher, Nina, Shimanovich, Iakov, Sitaru, Cassian, Terheyden, Patrick, Thaçi, Diamant, Ludwig, Ralf J., Schmidt, Enno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621786/
http://dx.doi.org/10.3389/fimmu.2023.1291590
Descripción
Sumario:Detlef Zillikens, MD, director and chair of the Department of Dermatology at the University of Lübeck, Lübeck, Germany, died in September 2022, aged only 64. He dedicated his professional life to autoimmune blistering diseases (AIBDs) and built his department into one of the world’s leading centers for these diseases. Herein, his professional life and the impact on the field of AIBDs and the research landscape at the University of Lübeck are addressed. With his warm, integrative, open-minded, ever-optimistic attitude, he was a highly reliable colleague, mentor, and friend to many in the field including each of the authors. Combined with his in-depth knowledge of dermatology, interest in many fields of life science, and hard work, Detlef Zillikens initiated the founding of two independent research institutes, the Lübeck Institute of Experimental Dermatology and the Institute and Comprehensive Center for Inflammation Medicine. He was also instrumental in establishing the Center for Research on Inflammation of the Skin, where in a new research building, over 140 scientists pursue research questions related to skin inflammation. By inviting numerous researchers and clinicians to his department and hosting two large international meetings, he brought the field of AIBDs much closer together and inspired multiple national and international research initiatives. His ideas will live on and grow in many of his colleagues and mentees.